This study is in progress, not accepting new patients
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
Paroxysmal Atrial Fibrillation, Atrial Fibrillation, FARAPULSE Pulsed Field Ablation System, RadioFrequency and Cryoballoon Ablation, Force Sensing Radiofrequency Ablation and Cryoballoon Ablation
Lead Scientist at UCSF
- Edward Gerstenfeld
Dr Gerstenfeld is the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at UCSF.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Farapulse, Inc.
- Study Type
- Expecting 900 study participants
- Last Updated